BRIDGEWATER, N.J. (AP) — BRIDGEWATER, N.J. (AP) — Insmed Inc. (INSM) on Thursday reported a loss of $370 million in its third quarter.
On a per-share basis, the Bridgewater, New Jersey-based company said it had a loss of $1.75.
The results missed Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for a loss of $1.32 per share.
The biopharmaceutical developing inhaled treatments for patients battling rare lung diseases posted revenue of $142.3 million in the period, which beat Street forecasts. Seven analysts surveyed by Zacks expected $114.6 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on INSM at https://www.zacks.com/ap/INSM
View Comments
Insmed: Q3 Earnings Snapshot
Published 1 week ago
Oct 30, 2025 at 11:17 AM
Negative
Auto